Company / Free Cash Flow per Share
Pacira BioSciences, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.96
FY2025
5-year range
$1.38 / $3.87
FY2021-FY2025
Trend
-23.5%
vs FY2024
Sector context
#28 of 192
Health Care
What the data says
Pacira BioSciences, Inc.'s free cash flow per share of $2.96 is higher than 85% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.33 in FY2017 to $3.87 in FY2024.
Based on SEC 10-K filings.
2.96 in FY2025 with a 5-year CAGR of +29.2%. Top quartile in the Health Care sector.
Declined from $3.04 to $2.96 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +29.2%
- 10-Year CAGR
- -
Sector benchmark
-10.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 23.5% year-over-year.
- Ranks #28 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.96 | -23.5% |
| FY2024 | $3.87 | +27.3% |
| FY2023 | $3.04 | +17.9% |
| FY2022 | $2.58 | +86.2% |
| FY2021 | $1.38 | +68.7% |
| FY2020 | $0.82 | +2381.8% |
| FY2019 | -$0.04 | -116.7% |
| FY2018 | $0.22 | +165.7% |
| FY2017 | -$0.33 | -238.0% |
| FY2016 | $0.24 | +169.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026